These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6781602)

  • 1. Clinical pharmacology. Drug monitoring.
    Moir DC
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):632-4. PubMed ID: 6781602
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between drug utilization and morbidity. A record linkage study.
    Skegg DC
    Acta Med Scand Suppl; 1984; 683():81-7. PubMed ID: 6588742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. America's "other" drug problem.
    Stratton MA
    Consult Pharm; 2009 Feb; 24(2):90, 92. PubMed ID: 19280760
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of drugs.
    Lancet; 1967 Jan; 1(7480):32-3. PubMed ID: 4163744
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical pharmacology in Australia.
    Nixon PF
    Clin Pharmacol Ther; 1974 Sep; 16(3):545-53. PubMed ID: 4412475
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective monitoring for adverse reactions to drugs in general practice.
    Drury M; Hull FM
    Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1305-7. PubMed ID: 6794834
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of marketed drugs in the United Kingdom.
    Cuthbert MF; Cone MD
    Agents Actions; 1978 Jun; 8(4):412-3. PubMed ID: 685778
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescriptions, adverse reactions, and the elderly.
    Lancet; 1986 Jul; 2(8497):40-1. PubMed ID: 2873338
    [No Abstract]   [Full Text] [Related]  

  • 9. Hunting rare adverse drug reactions.
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):342-3. PubMed ID: 6780017
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring adverse reactions to drugs.
    Dollery CT; Rawlins MD
    Br Med J; 1977 Jan; 1(6053):96-7. PubMed ID: 832028
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-marketing drug surveillance.
    Walden RJ; Prichard BN
    Br J Clin Pharmacol; 1978 Sep; 6(3):191-2. PubMed ID: 687497
    [No Abstract]   [Full Text] [Related]  

  • 12. Postmarketing surveillance of adverse reactions to drugs.
    Inman WHW
    Br Med J (Clin Res Ed); 1984 Apr; 288(6424):1155-6. PubMed ID: 6424767
    [No Abstract]   [Full Text] [Related]  

  • 13. New strategies for drug monitoring.
    Br Med J; 1977 Apr; 1(6065):861-2. PubMed ID: 851762
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription-related illness--a scandalous pandemic.
    McGavock H
    J Eval Clin Pract; 2004 Nov; 10(4):491-7. PubMed ID: 15482411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication for the elderly. A report of the Royal College of Physicians.
    J R Coll Physicians Lond; 1984 Jan; 18(1):7-17. PubMed ID: 6707984
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of marketed medicinal products: review procedures in Finland and Norway.
    Idänpään-Heikkilä J
    Agents Actions; 1978 Jun; 8(4):414-7. PubMed ID: 98975
    [No Abstract]   [Full Text] [Related]  

  • 17. Inappropriate prescribing in older people.
    Howard R; Avery T
    Age Ageing; 2004 Nov; 33(6):530-2. PubMed ID: 15501833
    [No Abstract]   [Full Text] [Related]  

  • 18. On how to improve drug use to minimise risks to patients.
    Woodward S
    Nurs Times; 2009 Sep 8-14; 105(35):33. PubMed ID: 19791677
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing for the elderly.
    Bliss MR
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):203-6. PubMed ID: 6789969
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the "E' book as a tool for drug monitoring.
    Skegg DC; Richards SM; Doll R
    J Epidemiol Community Health; 1981 Mar; 35(1):32-4. PubMed ID: 6790651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.